Health state utilities for skeletal-related events secondary to bone metastases. 2014

Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA, louis.matza@unitedbiosource.com.

BACKGROUND Patients with bone metastases often experience skeletal-related events (SREs). Although cost-utility models are used to examine treatments for metastatic cancer, limited information is available on utilities of SREs. The purpose of this study was to estimate the disutility of four SREs: spinal cord compression, pathological fracture, radiation to bone, and surgery performed to stabilize a bone. METHODS General population participants from the UK and Canada completed time trade-off (TTO) interviews to assess the utility of health states drafted based on literature review, clinician interviews, and patient interviews. Respondents first rated a health state describing cancer with bone metastases. Then, the SREs were added to this health state. RESULTS Interviews were completed with 187 participants (50.8 % male, 80.2 % white). Cancer with bone metastases without an SRE had a mean utility of 0.47 (SD = 0.43) on a standard utility scale (1 = full health, 0 = death). Of the SREs, spinal cord compression was associated with the greatest disutility (i.e., the utility decrease): -0.32 with paralysis and -0.22 without paralysis. Surgery had a disutility of -0.07. Leg, arm, and rib fractures had disutilities of -0.06, -0.04, and -0.03. Two weeks of daily radiation treatment had a disutility of -0.06, while two radiation appointments had the smallest impact on utility (-0.02). CONCLUSIONS All SREs were associated with statistically significant utility decreases, suggesting a perceived impact on quality of life beyond the impact of cancer with bone metastases. The resulting disutilities may be used in cost-utility models examining treatments to prevent SREs secondary to bone metastases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D002755 Choice Behavior The act of making a selection among two or more alternatives, usually after a period of deliberation. Approach Behavior,Approach Behaviors,Behavior, Approach,Behavior, Choice,Behaviors, Approach,Behaviors, Choice,Choice Behaviors
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man

Related Publications

Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
November 2008, BMJ (Clinical research ed.),
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
July 2016, Cureus,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
July 2012, The Journal of clinical endocrinology and metabolism,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
March 2015, Endocrine connections,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
December 2016, The Journal of clinical endocrinology and metabolism,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
January 2013, Journal of medical economics,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
November 2017, European journal of cancer care,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
June 2014, Nature reviews. Clinical oncology,
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
October 2012, Current oncology (Toronto, Ont.),
Louis S Matza, and Karen Chung, and Kate Van Brunt, and John E Brazier, and Ada Braun, and Brooke Currie, and Andrew Palsgrove, and Evan Davies, and Jean-Jacques Body
December 2022, Cureus,
Copied contents to your clipboard!